Overview

Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Status:
COMPLETED
Trial end date:
2023-12-30
Target enrollment:
Participant gender:
Summary
Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Phase:
PHASE2
Details
Lead Sponsor:
Zhejiang Cancer Hospital
Treatments:
nimotuzumab
Radiation